Sharvain Facades' managing director Boris Kostura said the collapse was attributable to construction delays at the market, and cost blowouts from labour and material expenses. “The perimeters, program ...
James Harrison, an Australian railway clerk ... produce antibodies in sufficient quality and quantity,” David Irving, director of research at Australian Red Cross Lifeblood, said in the statement.
James Harrison, an Australian who became a hero ... Lifeblood’s research director, David Irving, called this a "holy grail" in the field, with the hope that lab-grown Anti-D could one day ...
I’d call the director and say, ‘James is here. Can I bleed him, please?’” Harrison’s final tally was 1173 donations: 1163 from his right arm and 10 from his left (“It didn’t hurt in ...
Known as the "man with the golden arm," Harrison had an exceptionally rare ... Lifeblood's research director, David Irving, described the development of lab-made Anti-D as a "holy grail" due ...
James Harrison died in his sleep at a nursing ... "Creating a new therapy has long been a 'holy grail'," Lifeblood's research director David Irving said. He noted the scarcity of donors committed ...
James Harrison, one of the world’s most prolific ... has long been a ‘holy grail’,” said Lifeblood’s research director, David Irving. He also noted the difficulty of finding donors ...
James Harrison, the man with the golden arm ... David Irving, Lifeblood's Director of Research, emphasizes that creating a new therapy has long been the "holy grail." He points out the shortage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results